Efficacy and Safety With Ziprasidone in First-episode Psychosis

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chonbuk National University Hospital
• Collaborator: Pfizer
• Treatments: Ziprasidone

Criteria

Inclusion Criteria:

• Patients who meet DSM-IV criteria for first episode schizophrenia, schizophreniform disorder and schizoaffective disorder

Exclusion Criteria:

• Patients with previously prescribed antipsychotic medication in 2 weeks or more

• patients with substance-induced psychotic disorder, serious suicide attempt, neurological disorder, etc.